NG−Methyl-L-Arginine, an inhibitor of nitric oxide synthase, affects the central nervous system to produce peripheral hyperglycemia in conscious rats

Neuroendocrinology

Volumn 66, Issue 2, 1997, Pages 136-144

  Uemura, Kazumasa ^a   Tamagawa, Tatsuo ^a   Chen, Yi ^a   Maeda, Noriki ^a   Yoshioka, Shuko ^a   Itoh, Ken Ichi ^a   Miura, Hisayuki ^a   Iguchi, Akihisa ^a   Hotta, Nigishi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenal medulla; Catecholamines; Glucagon; Glucose; Glycemia; Insulin; Nitric oxide; Opioid peptides

Indexed keywords

ADRENALIN; ARGININE; GLUCAGON; GLUCOSE; INSULIN; NALOXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; PHENTOLAMINE; PHENTOLAMINE MESYLATE; PROPRANOLOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOGENIC AMINE; ENZYME INHIBITOR; N(G) METHYLARGININE; NARCOTIC ANTAGONIST; NITRIC OXIDE SYNTHASE;

ADRENALECTOMY; ADRENALIN BLOOD LEVEL; ADRENALIN RELEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN THIRD VENTRICLE; CARBOHYDRATE METABOLISM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ADRENALECTOMY; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARGININE; BIOGENIC MONOAMINES; BLOOD GLUCOSE; CENTRAL NERVOUS SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HYPERGLYCEMIA; INJECTIONS, INTRAVENTRICULAR; MALE; NARCOTIC ANTAGONISTS; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RATS; RATS, WISTAR;

EID: 0030611946     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000127231     Document Type: Article

References (36)

1. Knowles RG, Palacios M, Palmer RMJ, Moncada S: Formation of nitric oxide from I.-arginine in the central nervous system: A transduction mechanism for stimulation of soluble gua-nylatc cyclase. Proc Natl Acad Sei USA 1989; 86:5159-5162.
2. Rodrigo J, Springall DR, Utlenthal O, Bentura ML, Abadia-Molina F, Riveros-Moreno V, Martinez-Murillo R, Polak JM, Mongada S: Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc Lond Biol Sci 1994;345:175-221.
3. Grossman AB, Rossmanith WG, Kabigting EB, Cadd G, Clifton D, Steiner RA: The distribution of hypothalamic nitric oxide synthase mRNA in relation to gonadotrophin-releasing hormone neurons. J Endocrinol 1994; 140:R5-R8.
4. Bhat GK, Mahesh VB, Lamar CA, Ping L, Aguan K, Brann DW: Histochemical localization of nitric oxide neurons in the hypothalamus: Association with gonadotropin-releasing hormone neurons and co-localization with N-melhyl-Z-aspartaie receptors. Neurocndocri-nology 1995:62:187-197.
5. Garthwaite J, Charles SL, Chess-Williams R: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988;336:385-388.
6. Rcttori V, Ginteno M, Lyson K, McCann SM: Nitric oxide mediates norepinephrine-induced prostaglandin E: release from the hypothalamus. Proc Natl Acad Sci USA 1992:89:11543-11546.
7. Karanth S, Lyson K, McCann SM: Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 1993:90: 3383-3387.
8. Costa A, Trainer P, Besser M, Grossman A: Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res 1993:605:187-192.
9. Rivier C, Shen GH: In the rat. endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interlcukin-lp. vasopressin, and oxytocin. J Neurosci 1994:14:1985-1993.
10. Sakamua I, Togashi H, Yoshioka M. Saito H. Yanagida M. Tamura M. Kobayashi T. Yasuda H. Gross SS. Levi R: N-methyl-L-arginine, an inhibitor of L-argininc-dcrivcd nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ Res 1992:70:607-611.
11. Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, Levi R: A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol ExpTher 1992;262:343-347.
12. Frohman LA. Bemardis LL: Effect of hypotha-lamic stimulation on plasma glucose, insulin, and glucagon levels. Am J Physiol 1971:221: 1596-1603.
13. Helman AM, Amira R, Nicolaidis S, Assan R: Glucagon release induced by ventrolateral hypothalamic stimulation in the rat. Endocrinology 1980:106:1612-1619.
14. Biggers DW, Myers SR, Neal D, Stinson R, Cooper NB, Jaspan JB, Williams PE, Cherring-ton AD, Frizzell RT: Role of brain in counter-regulation of insulin-induced hypoglycemia in dogs. Diabetes 1989:37:7-16.
15. Brown MR, Tache Y, Fisher D: Central nervous system action of bombesin: Mechanism to induce hyperglycemia. Endocrinology 1979; 105:660-665.
16. Van Loon GR, Appel NM: 1-Endorphin-in-duccd hyperglycemia is mediated by increased central sympathetic outflow to adrenal medulla. Brain Res 1981;204:236-241.
17. Shintazu T, Fukuda A: Increased actitivities of glycogenolytic enzymes in liver after splanch-nic-nervc stimulation. Science 1965; 150:1607-1608.
18. Iguchi A, Gotoh M, Matsunaga H, Yatomi A, Honmura A, Yanase M, Sakamoto N: Relative contributions of the nervous system and hormones to CNS-mcdialcd hyperglycemia. Am J Physiol 1988;255:E920-E927.
19. Pellegrino LJ, Cushman AJ: A Stereotaxic Atlas of the Rat Brain. New York. Appleton-Cen-tury-Crofts. 1967.
20. Iguchi A, Gotoh M, Matsunaga H, Yatomi A, Uemura K, Miura H, Salake T, Tamagawa T, Sakamoto N: Central nervous system-mediated glucagon secretion is enhanced by aj-adrenore-ceplor activation. Endocrinology 1989; 125: 1581-1586.
21. Iguchi A, Gotoh M, Matsunaga H, Yatomi A, Honmura A, Yanase M, Sakamoto N: Mechanism of central hyperglycemic effect of cholinergic agonists in fasted rats. Am J Physiol 1986: 25 L: E431-E437.
22. Port Jr D, Graber AL, Kuzuya T, Williams RH: The effect of epinephrine on immunoreactivc insulin levels in man. J Clin Invest 1966:45: 228-236.
23. Ahren B, Lundquist I: Effects of a-adrcnoccp-tor blockade by phentolamine on basal and stimulated insulin secretion in the mouse. Acta Physiol Scand 1985:125:211-217.
24. Sacca L, Sherwin R, Eelig P: Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am J Physiol 1978: 235:E287.
25. Rizza RA, Cryer PE, Havmond MW, Gerich JE: Adrenergic mechansims for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 1980:65:682-689.
26. Viveros OH, Diliberto EJ, Hazum E, Chang KJ: Opiate-like materials in the adrenal medulla: Evidence for storage and secretion with catecholamines. Mol Pharmacol 1979:16:1101.
27. Iguchi A, Matsunaga H, Gotoh M, Nomura T, Yatomi A, Sakamoto N: Central hypcrglv-caemic effect of adrenaline and carbachol. Acta Endocrinol 1985;109:440-445.
28. Brown MR, Fisher LA: Brain peptide regulation of adrenal epinephrine secretion. Am J Physiol 1984:247:E41-E46.
29. Lenz HJ, Raedler A, Greten H, Brown MR: CRF initiates biological actions within the brain that are observed in response to stress. Am J Physiol 1987;252:R34-R39.
30. Dickie BGM, Lewis MJ, Davies JA: NMDA-induced release of nitric oxide potentiates aspartate overflow' from cerebellar slices. Neuro-sciLett 1992:138:145-148.
31. 5H]-dopantine from striatal slices. Neuro Report 1992:3:409-412.
32. Roscnblum WI, Nishimura H, Nelson GH: Endothelium-dependent L-Arg- and Z.-NMMA-sensitive mechanisms regulate tone of brain microvessels. Am J Physiol 1990;259:H1396-H1401.
33. Faraci FM, Breesc KR: Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-aspartate receptors in brain. Circ Res 1993:72:476-480.
34. Wang Q, Paulson OB, Lassen NA: Is autorcgu-lation of cerebral blood flow in rats influenced by nitro-L-arginine, a blocker of the synthesis of n.tric oxide? Acta Physiol Scand 1992:145: 297-298.
35. Schultz JA, Hoffman WE, Albrecht RF: Sympathetic stimulation with phvsostigmine worsens outcome from incomplete brain ischemia in rats. Anesthesiology 1993:79:114-121.
36. Robinson RL, Culberson JL, Carmichael SW: Influence of hypothalamic stimulation on the secretion of adrenal medullary catecholamines. J Auton Nerv Syst 1983;8:89-96.